Abstract:Due to its aggressiveness and unusual resistance to conventional therapies, pancreatic cancer is a highly lethal gastrointestinal malignancy with poor prognosis. According to the cancer stem cell hypothesis, there exists a fraction of cancer cells, that is, cancer stem cells, responsible for tumor maintenance and therapeutic failure. Herein we investigated the involvement of proto-oncogene Pim-3 in driving the stemness properties in pancreatic cancer. Expression levels of several stemness-associated markers were examined in several pancreatic cancer cell lines. The double positive (CD24+ESA+) and double negative (CD24-ESA-) pancreatic cancer cells were isolated from PANC-1 and L3.6pl, and their self-renewal ability, tumorigenicity as well as sensitivity to gemcitabine were then evaluated. Results showed that there existed heterogeneity in expression levels of stemness-associated surface markers among pancreatic cancer cell lines. CD24+ESA+ pancreatic cancer cells exhibited increased tumorigenicity and decreased chemosensitivity to gemcitabine as compared to CD24-ESA-cells. Besides, the double positive (CD24+ESA+) subpopulation also exhibited greater expression level of Pim-3 when compared with the double negative (CD24-ESA-) ones. Furthermore, silencing of Pim-3 in pancreatic cancer cells leads to decreased proportions of both single positive (CD24+ and ESA+) and double positive (CD24+ESA+) pancreatic cancer cells. Overexpression of Pim-3 was associated with increased levels of some stemness-associated transcription factors (STAT3, etc.). Moreover, the phosphorylation level and transcriptional activity of STAT3 were decreased in Pim-3 silenced pancreatic cancer cells and restoration of its activity results in restitution of stem cell-like phenotypes. Therefore, Pim-3 maintains stemness of pancreatic cancer cells via activating STAT3 signaling pathway and might be used as a novel therapeutic target in pancreatic cancer.

Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.

Pim-3 Promotes the Growth of Human Pancreatic Cancer in the Orthotopic Nude Mouse Model Through Vascular Endothelium Growth Factor

Pathophysiological Roles of Pim-3 Kinase in Pancreatic Cancer Development and Progression.

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Pim-3, A Proto-Oncogene With Serine/Threonine Kinase Activity, Is Aberrantly Expressed In Human Pancreatic Cancer And Phosphorylates Bad To Block Bad-Mediated Apoptosis In Human Pancreatic Cancer Cell Lines

Pim-3 Regulates Stemness of Pancreatic Cancer Cells Via Activating Stat3 Signaling Pathway

Roles of Pim-3, a Novel Survival Kinase, in Tumorigenesis.

Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.

Pim-3 is Expressed in Endothelial Cells and Promotes Vascular Tube Formation

Pim-3 Contributes to Radioresistance Through Regulation of the Cell Cycle and DNA Damage Repair in Pancreatic Cancer Cells

Aberrant Expression of Pim-3 Promotes Proliferation and Migration of Ovarian Cancer Cells

Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis.

Essential Contribution Of Ets-1 To Constitutive Pim-3 Expression In Human Pancreatic Cancer Cells

PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells

MicroRNA-33a-mediated Downregulation of Pim-3 Kinase Expression Renders Human Pancreatic Cancer Cells Sensitivity to Gemcitabine

Proto-Oncogene Serine/Threonine Kinase PIM3 Promotes Cell Migration Via Modulating Rho GTPase Signaling

Pim-3 Gene and Its Related Effect

PIM3 Kinase: A Promising Novel Target in Solid Cancers

Overexpression of Pim-1 in Bladder Cancer

Accelerated Hepatocellular Carcinoma Development in Mice Expressing the Pim-3 Transgene Selectively in the Liver.

Serine/Threonine Kinase Pim-2 Promotes Liver Tumorigenesis Induction Through Mediating Survival and Preventing Apoptosis of Liver Cell